Mirae Asset Global Investments Co. Ltd. Makes New Investment in Ventas, Inc. $VTR

Key Points

• Mirae Asset Global Investments opened a Ventas position in the third quarter, purchasing 136,225 shares worth about $11.6 million. Institutional investors collectively own 94.18% of the healthcare REIT.
• Ventas reported quarterly revenue of $1.83 billion, up 23% year over year and above estimates, but earnings per share of $0.13 fell short of the $0.98 consensus forecast.
• Analysts’ average rating is Moderate Buy, with an average price target of $99.41. Ventas also pays a quarterly dividend of $0.52, equivalent to a 2.3% yield at the article’s cited share price.

Mirae Asset Global Investments Co. Ltd. bought a new position in Ventas, Inc. (NYSE:VTR - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 136,225 shares of the real estate investment trust's stock, valued at approximately $11,582,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. bought a new position in Ventas during the 2nd quarter valued at about $4,953,439,000. Dimensional Fund Advisors LP raised its position in shares of Ventas by 3.6% in the first quarter. Dimensional Fund Advisors LP now owns 7,190,594 shares of the real estate investment trust's stock valued at $588,045,000 after buying an additional 253,019 shares during the last quarter. Legal & General Group Plc purchased a new position in Ventas during the 2nd quarter valued at about $501,850,000. Deutsche Bank AG acquired a new position in Ventas in the second quarter valued at $451,822,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Ventas by 5.5% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,981,404 shares of the real estate investment trust's stock worth $442,349,000 after acquiring an additional 258,859 shares during the period. Hedge funds and other institutional investors own 94.18% of the company's stock.

Ventas Trading Up 2.5%

NYSE VTR opened at $89.17 on Thursday. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.78. The company's fifty day simple moving average is $86.79 and its 200-day simple moving average is $86.59. The stock has a market cap of $47.16 billion, a P/E ratio of 22.97, a PEG ratio of 3.57 and a beta of 0.77. Ventas, Inc. has a 52 week low of $73.82 and a 52 week high of $101.60.

Ventas (NYSE:VTR - Get Free Report) last announced its earnings results on Tuesday, October 27th. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.98 by ($0.85). The firm had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.77 billion. Ventas had a net margin of 3.86% and a return on equity of 1.86%. The company's quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.88 EPS. Equities research analysts predict that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Ventas Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were paid a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. Ventas's dividend payout ratio is currently 392.45%.

Wall Street Analysts Forecast Growth

VTR has been the subject of a number of research reports. BNP Paribas Exane lifted their price objective on Ventas from $93.00 to $110.00 and gave the company an "outperform" rating in a research report on Thursday, July 30th. The Goldman Sachs Group lifted their price objective on shares of Ventas from $110.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, July 24th. Barclays cut their price target on shares of Ventas from $102.00 to $91.00 and set an "equal weight" rating on the stock in a report on Tuesday, October 13th. Wells Fargo & Company dropped their price objective on shares of Ventas from $104.00 to $96.00 and set an "overweight" rating for the company in a report on Monday, October 19th. Finally, Mizuho boosted their target price on shares of Ventas from $98.00 to $104.00 and gave the company an "outperform" rating in a research report on Wednesday, July 22nd. Seventeen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, Ventas has an average rating of "Moderate Buy" and an average price target of $99.41.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.